Page last updated: 2024-10-22

albuterol and Carotid Artery Diseases

albuterol has been researched along with Carotid Artery Diseases in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalra, L1
Iveson, E1
Rambaran, C1
Sherwood, R1
Chowienczyk, P1
Ritter, J1
Shah, A1
Forrester, T1

Trials

1 trial available for albuterol and Carotid Artery Diseases

ArticleYear
An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans.
    Atherosclerosis, 2008, Volume: 199, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Black People; Body Mass Index; Carotid Arteries; Carotid

2008